[1]

Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48.

doi: 10.1001/jamaoncol.2016.5688
[2]

Holme Ø, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013(9):CD009259..:
[3]

Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med. 1993;328:1365–71.

doi: 10.1056/NEJM199305133281901
[4]

Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326(10):653–7.

doi: 10.1056/NEJM199203053261001
[5]

Health, United States, 2016: with chartbook on long-term trends in health. Hyattsville, MD: National Center for Health Statistics; 2017.
[6]

Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K. The IARC perspective on colorectal cancer screening. N Engl J Med. 2018;378(18):1734–40.

doi: 10.1056/NEJMsr1714643
[7]

Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23(20):3632–42.

doi: 10.3748/wjg.v23.i20.3632
[8]

Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, et al. Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet. 1989;1(8648):1160–4.
[9]

Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999;91(5):434–7.

doi: 10.1093/jnci/91.5.434
[10]

Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, et al. Colonoscopy versus fecal immunochemical testing in colorectalcancer screening. N Engl J Med. 2012;366(8):697–706.

doi: 10.1056/NEJMoa1108895
[11]

Smith A, Young GP, Cole SR, Bampton P. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107(9):2152–9.

doi: 10.1002/cncr.22230
[12]

Dominitz JA, Robertson DJ, Ahnen DJ, Allison JE, Antonelli M, Boardman KD, et al. Colonoscopy vs. fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM): rationale for study design. Am J Gastroenterol. 2017;112(11):1736–46.

doi: 10.1038/ajg.2017.286
[13]

Briss P, Rimer B, Reilley B, Coates RC, Lee NC, Mullen P, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26(1):67–80.

doi: 10.1016/j.amepre.2003.09.012
[14]

Schroy PC 3rd, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, et al. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med. 2012;43(6):573–83.

doi: 10.1016/j.amepre.2012.08.018
[15]

Gimeno Garcia AZ. Factors influencing colorectal cancer screening participation. Gastroenterol Res Pract. 2012;2012:483417.
[16]

Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50(1–2):3–10.
[17]

Hol L, de Bekker-Grob EW, van Dam L, Donkers B, Kuipers EJ, Habbema JD, et al. Preferences for colorectal cancer screening strategies: a discrete choice experiment. Br J Cancer. 2010;102(6):972–80.

doi: 10.1038/sj.bjc.6605566
[18]

Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001;16(12):822–30.

doi: 10.1046/j.1525-1497.2001.10337.x
[19]

Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechère-Bertschi A. 1999–2009 trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS One. 2012;7(6):e39877.

doi: 10.1371/journal.pone.0039877
[20]

Selby K, Cornuz J, Gachoud D, Bulliard JL, Nichita C, Dorta G, et al. Training primary care physicians to offer their patients faecal occult blood testing and colonoscopy for colorectal cancer screening on an equal basis: a pilot intervention with before-after and parallel group surveys. BMJ Open. 2016;6(5):e011086.

doi: 10.1136/bmjopen-2016-011086
[21]

Huisman M, Kunst AE, Mackenbach JP. Educational inequalities in smoking among men and women aged 16 years and older in 11 European countries. Tob Control. 2005;14(2):106–13.

doi: 10.1136/tc.2004.008573
[22]

Garner TI, Ruiz-Castillo J, Sastre M. The influence of demographics and household-specific price indices on consumption-based inequality and welfare: a comparison of spain and the United States. South Econ J. 2003;70:22–48.
[23]

Sullivan GM, Artino AR Jr. Analyzing and interpreting data from likert-type scales. J Grad Med Educ. 2013;5(4):541–2.

doi: 10.4300/JGME-5-4-18
[24]

Bibbins-Domingo K, Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW Jr, Epling JW, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–75.

doi: 10.1001/jama.2016.5989
[25]

DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23(2):169–74.

doi: 10.1007/s11606-007-0480-1
[26]

Rat C, Pogu C, Le Donné D, Latour C, Bianco G, Nanin F, et al. Effect of physician notification regarding nonadherence to colorectal cancer screening on patient participation in fecal immunochemical test cancer screening: a randomized clinical trial. JAMA. 2017;318(9):816–24.

doi: 10.1001/jama.2017.11387
[27]

Singal AG, Gupta S, Skinner CS, Ahn C, Santini NO, Agrawal D, et al. Effect of colonoscopy outreach vs. fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial. JAMA. 2017;318(9):806–15.

doi: 10.1001/jama.2017.11389
[28]

Bulliard JL, Germann S. Enquête sur le dépistage du cancer colorectal auprès des médecins de premier recours genevois. Lausanne, Division des maladies chroniques, Institut universitaire de médecine sociale et préventive (IUMSP). 2016.